Frontiers in Pharmacology has announced the appointment of Prof. Heike Wulff as the new Field Chief Editor. Prof. Wulff will share the position in a transitional phase with Prof. Théophile Godfraind until early 2018.
As a field, Pharmacology is increasingly far-reaching. As a Principal Investigator at UC Davis specialising in ion-channel pharmacology, Prof. Wulff is involved in the development of potential treatments for cardiovascular, as well as autoimmune and neurological diseases. Furthermore, she is the director of the Probe and Pharmaceutical Optimization core of the UC Davis CounterACT Center of Excellence. Countermeasures Against Chemical Threats (CounterACT) is a trans-NIH research program focused on the development of medical countermeasures to chemical agents - released into the population either accidentally or deliberately.
In this dynamic context, maintaining a clear focus on fundamental pharmacological principles - and their development - is something that Prof. Wulff believes will be vital in the years to come, and something Frontiers in Pharmacology can take a leading role in.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
